We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 56.00 | 55.00 | 57.00 | 56.00 | 56.00 | 56.00 | 168,506 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 23.25M | -24.95M | -0.0695 | -8.06 | 201.06M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/4/2024 21:49 | It's probably likely that all of these patients participating in the trial should be dead by now. They were terminal with only a few months left to live. This is why they were selected for this extremely risky safety trial. The safety trial wasn't expected to help them. It's just to test safety. These selfless people have been given a small miracle with AVA6000. Just hope they continue to recover further. | rajraj b | |
09/4/2024 21:23 | We will need the actual data to understand this. Wait for the seminar at 5.30pm. | bonzo | |
09/4/2024 21:12 | Are you still in ama or buying back in the morning? Still here. Where's whitey? | cheshire pete | |
09/4/2024 21:03 | On second thoughts !!,perhaps it should be called the "Lazarus" drug ! One patient managed his 60th birthday against the odds !! | fieldhouse | |
09/4/2024 20:57 | Well, a bit disappointing !! No Lazarus Effect !! Can't quite bring back the dead !! Can do Just what they said on the can !! Very happy to hold . The science is good .Take note company mockers | fieldhouse | |
08/4/2024 12:06 | Any future for this company?? Years after years no results & no revenues | blackhorse23 | |
08/4/2024 10:40 | Lol. Obviously tongue in cheek | coley15 | |
08/4/2024 10:32 | ...says the trader | conviboyz | |
08/4/2024 09:22 | The traders return. Shallow as an eight inch puddle. Devious spawn. | amanitaangelicus | |
06/4/2024 12:49 | ..talking of double bottoms. How are you and Baldrick getting on | conviboyz | |
06/4/2024 11:45 | A very bullish tweet by the Head of R&D re next week's presentation: https://x.com/coughl | northwards | |
06/4/2024 00:35 | Ooo woooopy blooody dooo, more blooody jargen | repins1 | |
05/4/2024 13:58 | Jeez beatme1 - don't you have a spellchecker? | wsm812 | |
05/4/2024 13:31 | "is regurgitates bull" ? | coley15 | |
05/4/2024 13:18 | Hdmtwww!.£/!: d | beatme1 | |
04/4/2024 15:13 | 40-45p ...big double bottom on the 3 yr. If the share price can recover on news, there.s a nice gap that needs filling. Mkt cap still around £125m - that.ll include cash in bank. Still too high for where we.re at. No way we.ll get through to 2025 end stages without more raises, once the current placing has been burned through. Convis playing havoc at the mo. Until the rest is set, nobody will be interested. TimeLord Smith will have had to give reassurances to the ii.s who took the recent offer up. What those assurances were, one can only guess. Rest assured, you.ll be the last to know. | amanitaangelicus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions